IMJUDO vs PEGASYS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. IMJUDO and PEGASYS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IMJUDO	PEGASYS
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TREMELIMUMAB-ACTL	PEGINTERFERON ALFA-2A
Manufacturer	Astrazeneca Ab	Pharmaand Gmbh
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	Boxed warning
Treats	Hepatocellular Carcinoma	Brain Neoplasms, Renal Cell Carcinoma, Cryoglobulinemia

imjudo pegasys

Rating

New

Pharmacy pays

—

Type

Active ingredient

TREMELIMUMAB-ACTL

PEGINTERFERON ALFA-2A

Manufacturer

Astrazeneca Ab

Pharmaand Gmbh

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Boxed warning

Treats

Hepatocellular Carcinoma

Brain Neoplasms, Renal Cell Carcinoma, Cryoglobulinemia

Frequently asked questions

What is the difference between Imjudo and Pegasys?

Imjudo contains Tremelimumab-Actl, while Pegasys contains Peginterferon Alfa-2a — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.